• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用混合 [C]间羟麻黄碱正电子发射断层扫描和心脏磁共振成像检测法布里病的交感神经去神经缺陷。

Detection of sympathetic denervation defects in Fabry disease by hybrid [C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.

机构信息

Division of Cardiology, Department of Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

出版信息

J Nucl Cardiol. 2023 Oct;30(5):1810-1821. doi: 10.1007/s12350-023-03205-7. Epub 2023 Feb 28.

DOI:10.1007/s12350-023-03205-7
PMID:36855009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10558396/
Abstract

BACKGROUND

Myocardial glycosphingolipid accumulation in patients with Fabry disease (FD) causes biochemical and structural changes. This study aimed to investigate sympathetic innervation in FD using hybrid cardiac positron emission tomography (PET)/magnetic resonance imaging (MRI).

METHODS AND RESULTS

Patients with different stages of Fabry disease were prospectively enrolled to undergo routine CMR at 1.5T, followed by 3T hybrid cardiac PET/MRI with [C]meta-hydroxyephedrine ([11C]mHED). Fourteen patients with either no evidence of cardiac involvement (n = 5), evidence of left ventricular hypertrophy (LVH) (n = 3), or evidence of LVH and fibrosis via late gadolinium enhancement (LGE) (n = 6) were analyzed. Compared to patients without LVH, patients with LVH or LVH and LGE had lower median T1 relaxation times (ms) at 1.5 T (1007 vs. 889 vs. 941 ms, p = 0.003) and 3T (1290 vs. 1172 vs. 1184 p = .014). Myocardial denervation ([11C]mHED retention < 7%·min) was prevalent only in patients with fibrosis, where a total of 16 denervated segments was found in two patients. The respective area of denervation exceeded the area of LGE in both patients (24% vs. 36% and 4% vs. 32%). However, sympathetic innervation defects ([11C]mHED retention ≤ 9%·min) occurred in all study groups. Furthermore, a reduced sympathetic innervation correlated with an increased left ventricular mass (p = .034, rs = - 0.57) and a reduced global longitudinal strain (GLS) (p = 0.023, rs = - 0.6).

CONCLUSION

Hybrid cardiac PET/MR with [11C]mHED revealed sympathetic innervation defects, accompanied by impaired GLS, in early stages of Fabry disease. However, denervation is only present in patients with advanced stages of FD showing fibrosis on CMR.

摘要

背景

法布里病(FD)患者心肌糖脂积累导致生化和结构改变。本研究旨在使用心脏正电子发射断层扫描(PET)/磁共振成像(MRI)混合技术研究 FD 的交感神经支配。

方法和结果

前瞻性纳入不同阶段 FD 患者,在 1.5T 进行常规 CMR,随后在 3T 行心脏 PET/MRI 混合检查,采用[C]间羟麻黄碱([11C]mHED)。分析了 14 名无心脏受累(n=5)、左心室肥厚(LVH)(n=3)或 LVH 合并延迟钆增强(LGE)纤维化(n=6)的患者。与无 LVH 患者相比,LVH 或 LVH 合并 LGE 患者的 1.5T(1007 对 889 对 941ms,p=0.003)和 3T(1290 对 1172 对 1184p=0.014)的 T1 弛豫时间中位数较低。心肌去神经支配([11C]mHED 保留<7%·min)仅见于纤维化患者,其中 2 例各有 16 个去神经支配节段。在这两名患者中,去神经支配的区域均超过 LGE 区域(24%对 36%和 4%对 32%)。然而,所有研究组均存在交感神经支配缺陷([11C]mHED 保留≤9%·min)。此外,交感神经支配减少与左心室质量增加(p=0.034,rs=-0.57)和整体纵向应变(GLS)降低(p=0.023,rs=-0.6)相关。

结论

心脏[11C]mHED PET/MRI 混合技术显示,早期 FD 患者存在交感神经支配缺陷,同时伴有 GLS 降低。然而,只有在 CMR 显示纤维化的 FD 晚期患者中才出现去神经支配。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/e4f5638b9e74/12350_2023_3205_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/e559bc33e141/12350_2023_3205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/364fd2f14c6f/12350_2023_3205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/593f2d57ccbe/12350_2023_3205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/e4f5638b9e74/12350_2023_3205_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/e559bc33e141/12350_2023_3205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/364fd2f14c6f/12350_2023_3205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/593f2d57ccbe/12350_2023_3205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a32/10558396/e4f5638b9e74/12350_2023_3205_Fig4_HTML.jpg

相似文献

1
Detection of sympathetic denervation defects in Fabry disease by hybrid [C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.应用混合 [C]间羟麻黄碱正电子发射断层扫描和心脏磁共振成像检测法布里病的交感神经去神经缺陷。
J Nucl Cardiol. 2023 Oct;30(5):1810-1821. doi: 10.1007/s12350-023-03205-7. Epub 2023 Feb 28.
2
Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.通过心血管磁共振评估法布里病的基底-顶点周向应变梯度缺失:与 T1 映射、晚期钆增强和心肌肥厚的关系。
J Cardiovasc Magn Reson. 2019 Aug 1;21(1):45. doi: 10.1186/s12968-019-0557-0.
3
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.法布瑞氏病心肌表型的肥大前期和可检测存储前期。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
4
Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: C-hydroxyephedrine PET study.射血分数保留的心力衰竭中心肌交感神经去神经支配、收缩功能障碍和纤维化的区域相互作用:C-羟基麻黄碱 PET 研究。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1897-1905. doi: 10.1007/s00259-017-3760-y. Epub 2017 Jun 26.
5
Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease.法布里病患者心脏事件的临床和 CMR 特征。
Int J Cardiol. 2023 Jul 1;382:46-51. doi: 10.1016/j.ijcard.2023.04.016. Epub 2023 Apr 10.
6
Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients.法布里病患者心脏磁共振钆增强的临床发现。
J Cardiol. 2020 Jan;75(1):27-33. doi: 10.1016/j.jjcc.2019.09.002. Epub 2019 Oct 15.
7
Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.通过生物标志物评估联合 LGE 心脏 MRI 早期检测 Fabry 病的器官受累:来自 SOPHIA 研究的结果。
Mol Genet Metab. 2019 Feb;126(2):169-182. doi: 10.1016/j.ymgme.2018.11.005. Epub 2018 Nov 12.
8
2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.使用11C-羟基麻黄碱PET研究特发性帕金森病中心脏交感神经支配的2年自然衰退情况。
J Nucl Med. 2017 Feb;58(2):326-331. doi: 10.2967/jnumed.116.176891. Epub 2016 Aug 18.
9
Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.心脏磁共振左心室肥厚和晚期钆增强与法布瑞病的不良心脏事件相关。
Radiology. 2020 Jan;294(1):42-49. doi: 10.1148/radiol.2019191385. Epub 2019 Oct 29.
10
Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.区域性心肌交感神经去神经支配可预测缺血性心肌病患者发生心原性猝死的风险。
J Am Coll Cardiol. 2014 Jan 21;63(2):141-9. doi: 10.1016/j.jacc.2013.07.096. Epub 2013 Sep 25.

引用本文的文献

1
Cardiac involvement in Anderson-Fabry disease. The role of advanced echocardiography.心脏受累在安德森-法布里病中的情况。先进超声心动图的作用。
Front Cardiovasc Med. 2024 Sep 2;11:1440636. doi: 10.3389/fcvm.2024.1440636. eCollection 2024.
2
Impairment of sympathetic activity in Fabry disease cardiomyopathy: A further challenge for cardiac imaging.法布里病心肌病中交感神经活动受损:心脏成像面临的又一挑战。
J Nucl Cardiol. 2023 Oct;30(5):1822-1824. doi: 10.1007/s12350-023-03261-z. Epub 2023 May 4.

本文引用的文献

1
Fabry Disease and the Heart: A Comprehensive Review.《法布瑞病与心脏:全面综述》。
Int J Mol Sci. 2021 Apr 23;22(9):4434. doi: 10.3390/ijms22094434.
2
Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.成人和儿童心血管磁共振(CMR)的参考范围(“正常值”):2020 更新。
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87. doi: 10.1186/s12968-020-00683-3.
3
Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?多模态影像学方法在法布瑞心肌病中的应用:核医学在其中有作用吗?
J Nucl Cardiol. 2022 Jun;29(3):1439-1445. doi: 10.1007/s12350-020-02124-1. Epub 2020 May 6.
4
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.酶替代治疗 1 年后法布病患者心肌储存、炎症和心脏表型。
Circ Cardiovasc Imaging. 2019 Dec;12(12):e009430. doi: 10.1161/CIRCIMAGING.119.009430. Epub 2019 Dec 12.
5
Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.心脏磁共振左心室肥厚和晚期钆增强与法布瑞病的不良心脏事件相关。
Radiology. 2020 Jan;294(1):42-49. doi: 10.1148/radiol.2019191385. Epub 2019 Oct 29.
6
Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries.大动脉调转术后青年人的心肌血流和心脏交感神经支配。
Int J Cardiol. 2020 Jan 15;299:110-115. doi: 10.1016/j.ijcard.2019.07.041. Epub 2019 Jul 13.
7
Anderson-Fabry disease: Worthy to in-SPECT the nerves?
J Nucl Cardiol. 2021 Apr;28(2):650-652. doi: 10.1007/s12350-019-01787-9. Epub 2019 Jun 19.
8
Focal reduction in left ventricular I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease.安德森-法布里病患者左心室间碘苄胍摄取灶性减少及收缩功能受损。
J Nucl Cardiol. 2021 Apr;28(2):641-649. doi: 10.1007/s12350-019-01734-8. Epub 2019 May 13.
9
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.应用正电子发射断层扫描-磁共振成像技术评估安德森-法布里病患者不同阶段的心功能障碍:AFFINITY 研究组。
Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1004-1011. doi: 10.1093/ehjci/jez039.
10
First-in-Human Studies of [F] Fluorohydroxyphenethylguanidines.首例氟羟苯乙基胍的人体研究。
Circ Cardiovasc Imaging. 2018 Dec;11(12):e007965. doi: 10.1161/CIRCIMAGING.118.007965.